Clinical Trials Directory

Trials / Completed

CompletedNCT02873988

Regeneration of Bronchial Epithelium During Chronic Obstructive Pulmonary Disease

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
CHU de Reims · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Airway epithelium integrity is essential to maintain its role of mechanical and functional barrier. Recurrent epithelial injuries require a complex mechanism of repair to restore its integrity. In chronic obstructive pulmonary disease (COPD), an abnormal airway epithelial repair may participate in airway remodelling. The objective was to determine if airway epithelial wound repair of airway epithelium is abnormal in COPD.

Detailed description

Patients scheduled for lung resection were prospectively recruited. Demographic, clinical data and pulmonary function tests results were recorded. Emphysema was visually scored and histological remodelling features were noted. Primary bronchial epithelial cells (BEC) were extracted and cultured for wound closure assay. The investigators determined the mean speed of wound closure (MSWC) and cell proliferation index, matrix metalloprotease (MMP)-2, MMP-9 and cytokines levels in supernatants of BEC 18 hours after cell wounding. In a subset of patients, bronchiolar epithelial cells were also cultured for wound closure assay for MSWC analyze.

Conditions

Interventions

TypeNameDescription
OTHERbronchial epithelial cell culture

Timeline

Start date
2012-03-01
Primary completion
2013-12-01
Completion
2014-05-01
First posted
2016-08-22
Last updated
2016-08-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02873988. Inclusion in this directory is not an endorsement.